Change to Clarity’s Board of Directors
Sydney, Australia 9 April 2026 Clarity Pharmaceuticals (ASX: CU6) (“Clarity” or “Company”), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, announces that its Executive Director, Dr Colin Biggin, is stepping down from the Board. He will continue in his role as Chief Operating Officer…